Categories: The Charlton Centre

Rheumatology & Weight

We often hear of the many great impacts maintaining a health weight can have on our health. Losing weight has always been known as a benefit for our joints, especially people with osteoarthritis. At the recent American College of Rheumatology Conference, a study was presented looking at the impact of weight loss on rheumatoid arthritis, an autoimmune disease.

It was found that for people who have a BMI (body mass index) over 25, that a weight loss of 5 kg resulted in a 42% improvement in their level of overall disease activity compared to an improvement of only 19% in those who did not lose weight. Both groups were on similar treatments. Even a 1kg loss of body weight showed improvement in lowering disease activity as excess fat is known to produce several inflammatory chemicals in the body.


Our pharmacist, Carolyn Whiskin, recently returned from The American College of Rheumatology Conference, the largest international meeting held for rheumatology. Over 15,000 health professionals from around the world specializing in research and the care of people with arthritis were in attendance. Today’s blog post is one several to come with information Carolyn learned at the Conference.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 weeks ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

1 month ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

2 months ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

3 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago